![]() |
New to the Huntington's
Disease Lighthouse? |
||
| |
| |
| |
| |
| |
| |
| |
||
Expression of dominant-negative Dmp53 in the adult fly brain inhibits insulin signalingJohannes H. Bauer, Chengyi Chang, Siti Nur Sarah Morris, Suzanne Hozier, Sandra Andersen, Joshua S. Waitzman, and Stephen L. Helfand The Press Release Key to longer life (in flies) lies in just 14 brain cells PROVIDENCE, R.I. [Brown University] -- Two years ago, Brown University researchers discovered something startling: Decrease the activity of the cancer-suppressing protein p53 and you can make fruit flies live significantly longer. Now the same team reports an intriguing follow-up finding. The p53 protein, they found, may work its lifespan-extending magic in only 14 insulin-producing cells in the fly brain. “It’s quite surprising,” said Johannes Bauer, a postdoctoral research fellow at Brown. “In the fruit fly brain, there are tens of thousands of cells. But we found that it takes a reduction of p53 activity in only 14 of those brain cells to extend lifespan. It was like finding a needle in the haystack – a very small needle at that.” Bauer is the lead author of the research report, published in the Proceedings of the National Academy of Sciences. Brown biology professor Stephen Helfand, senior scientist on the project, will discuss the findings in his keynote address at the Gordon Research Conferences on the Biology of Aging, to be held Sept. 23-28, 2007, in Les Diablerets, Switzerland. P53 is sometimes called “guardian of the genome” for defending cells against DNA damage. Not enough of the protein can cause cancer; too much, however, can shorten lifespan. But in 2005, Helfand and his lab showed that a targeted decrease of p53 in fruit flies – a decrease specifically in their brain cells – allowed flies to live healthy lives that were as much as 58 percent longer. But how, exactly, does p53 do its work in the brain? To find out, Bauer spent a year conducting painstaking experiments. He’d take a batch of young flies, each genetically altered to reduce p53 activity in a small portion of their nervous systems, and watch the flies age. Time and again, the flies lived for about two months – the average lifespan for these insects. But when Bauer manipulated a cluster of 14 insulin-producing cells in their brains, the flies lived about 15 to 20 percent longer. Bauer ran the experiment again and again – and got the same result. Bauer and Helfand then wanted to know if this was caloric restriction at work. Studies have shown that low-calorie diets can significantly increase the lifespan of flies, worms, mice and rats. The phenomenon is of intense interest to researchers who study aging. They want to know if caloric restriction works in people and if drugs could be made to mimic its effects. So researchers restricted the diets of the flies and ran the same experiments. The calorie-restricted flies didn’t live any longer when p53 was reduced in the insulin-producing cells. This evidence supports the notion that p53 reduction is one of the direct effects of caloric restriction. Even more intriguing, Helfand said, is the fact that the 14 insulin-producing cells that seem to be critical for lifespan extension are the equivalent of beta cells in the human pancreas. Beta cells make and release insulin, the hormone that controls the level of glucose in the blood. The research team found that when p53 activity drops, so does insulin-responsive activity in the fat body, the major metabolic organ in the fruit fly. “Our findings suggest that lifespan regulation is linked to metabolic regulation,” said Helfand, a professor in Brown’s Department of Molecular Biology, Cell Biology and Biochemistry. “The findings also suggest a tight connection between aging and diabetes. And we may have a new laboratory model for studying diabetes and other metabolic diseases.” The rest of the team included senior research assistants Suzanne Hosier and Chengyi Chang and undergraduate students Siti Nur Sarah Morris, Sandra Andersen, and Joshua Waitzman. The National Institute on Aging, the Donaghue Foundation, the Ellison Medical Foundation and the American Federation for Aging Research supported the research. the Abstract In Drosophila melanogaster, p53 (Dmp53) is an important mediator of longevity. Expression of dominant-negative (DN) forms of Dmp53 in adult neurons, but not in muscle or fat body cells, extends lifespan. The lifespan of calorie-restricted flies is not further extended by simultaneously expressing DN-Dmp53 in the nervous system, indicating that a decrease in Dmp53 activity may be a part of the CR lifespan-extending pathway in flies. In this report, we show that selective expression of DN-Dmp53 in only the 14 insulin-producing cells (IPCs) in the brain extends lifespan to the same extent as expression in all neurons and this lifespan extension is not additive with CR. DN-Dmp53-dependent lifespan extension is accompanied by reduction of Drosophila insulin-like peptide 2 (dILP2) mRNA levels and reduced insulin signaling (IIS) in the fat body, which suggests that Dmp53 may affect lifespan by modulating insulin signaling in the fly. Source: Proceedings of the Nat'l Academy of Sciences of the USA. August 14, 2007, vol. 104 no. 33: 13355-60
|
Research focusing on the formation of aggregates caused by HD
Research related to the role Brain Derived Neurotrophic Factor has on the pathology of HD in the brain
Learn more about the clinical trial process, trials that have been conducted and those that are underway.
Research related to drugs and supplements that may delay onset and slow progression of Huntington's Disease.
Research focusing on gene therapy.
Research focusing on gene transcription.
General research related to HD
Research studying the genetics of Huntington's Disease
Research studying the Immune System and it's effect on the progression of HD
Research studying the brain tissue and research related to stem cells
26 Sep 2007
Press release for the BDNF neurogenesis study.
25 Aug 2007
Gene Expression Analysis and Extra-Mitochondrial Energy Metabolism
The HD protein causes a depletion in cellular energy but not through direct effects on the mitochondria, the cell's energy factory.
24 Aug 2007
RE1/NRSE Mediated Gene Transcription
Exciting research suggests that restoring the expression of the genes that the HD protein suppresses could be a major treatment.
20 Aug 2007
The Molecular Zip Code Research Yields a Drug Target
The molecular zip code research suggests that a kinase inhibitor could be a major treatment for Huntington
19 May 2007
D1 receptors and HD
Researchers generated a mouse which progressively lost Dopamine 1 receptor cells and got Huntington's Disease like symptoms.
1 Apr 2007
Copper in the HD brain
Researchers have discovered that excess copper plays a role in Huntington's Disease pathology.
13 Feb 2007
Molecular Zipcodes Provide Address for HD Protein
New findings based on new technology show that the HD protein is being misdirected within the cell. Small molecules are being developed which might place a 'molecular zip code' on the problem.
6 Feb 2007
NCAMs in the HD mice
Problems with NCAMs may explain cognitive and olfactory dysfunction in HD.
19 Dec 2006
Stem Cells and The Aging Brain
Stem cells are still present in the middle aged brain; they just aren't dividing.
8 Dec 2006
ReNeuron Files Application with FDA to Begin Phase I Study of Stem Cell Treatment for Stroke Patients.
A company currently doing stem cell research in animal models of HD, has filed an application with the FDA for permission to begin clinical trials of stem cell treatments for stroke victims.
All Updates for The Brain |
|||||||||||||||||
| Disclaimer &
Privacy Policy | |
|